Less than 10% of all cases of ALS are associated with hexanucleotide expansions in C9orf72, or pathological mutations in SOD1, TARDBP or FUS. Moreover, such cases are clinically indistinguishable from apparently sporadic cases, and encompass the full range of clinical phenotypes. The gene discussed is FUS; the disease is amyotrophic lateral sclerosis.